KFDA grants Apatoxin inj. as novel natural drug
Published: 2003-05-12 06:57:00
Updated: 2003-05-12 06:57:00
The Korea Food and Drug Administration announced on May 3 that Guju's Apatoxin inj. (dried bee venom) received the first manufacturing approval for the treatment of osteoarthritis as a new natural drug for the first time in Korea.
Apatoxin inj. is prepared in a manner such that the venom of It...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
